Operation Desert Shield: medical aspects of weapons of mass destruction.
Our concern over possible use of weapons of mass destruction against U.S. forces in the Middle East has increased because Iraq has violated the Geneva Protocol of 1925 and the 1972 Biological Weapons Convention, attempted to acquire nuclear capability and delivery systems, and is reported to be developing biological weapons. The Army Medical Department has had no experience, since World War I, in the management and treatment of mass casualties contaminated by chemical agents, and has never treated casualties resulting from the use of nuclear or biological weapons used against our soldiers. Management and diagnosis of casualties will be complicated by their possible exposure to a mixture of chemical warfare and biological warfare agents. Triage is an essential aspect in the management of mass casualties since the number of injured patients will exceed the maximum medical capability to treat each patient on arrival. All levels of medical support must be prepared to protect themselves, their equipment and supplies, and their patients from contamination. In contaminated operations on the integrated battlefield, it will be of utmost importance to incorporate flexibility and innovation to match the medical and tactical situation.
Knudson
G B
GB
Department of Pathology, Letterman Army Medical Center, Presidio of San Francisco, CA 94129-6700.
D001694:Biological Warfare; D002618:Chemical Warfare; D003666:Decontamination / Q000379:methods*; D006801:Humans; D008877:Middle East; D009689:Nuclear Warfare; D011482:Protective Devices / Q000600:supply & distribution